INFINITY PHARMACEUTICALS ANNOUNCES SMALL MOLECULE COLLABORATION

Infinity Pharmaceuticals has entered into a collaborative agreement with Novartis to jointly design a collection of novel small molecules to be synthesized by Infinity using its innovative chemical technology platform. The collaboration represents a unique opportunity for both companies given the synergy between Infinity's diversity oriented synthesis expertise, and Novartis' wealth of experience with natural products and accumulated expertise in the identification of preferred pharmacophores.

Biospace (http://www.biospace.com/news_story.cfm?StoryID=18586420)